Literature DB >> 27130528

Circulating nucleosomes are associated with mortality in pediatric acute respiratory distress syndrome.

Nadir Yehya1, Neal J Thomas2, Susan S Margulies3.   

Abstract

Mechanisms underlying pediatric acute respiratory distress syndrome (PARDS) are poorly understood. The recent implication of circulating nucleosomes as pathogenic in sepsis and trauma-associated ARDS in adults led us to investigate the significance of nucleosomes in PARDS. We conducted a prospective, observational study on children with PARDS at the Children's Hospital of Philadelphia between July 2014 and September 2015. Plasma was collected within 48 h of PARDS onset and nucleosomes quantified by enzyme-linked immunosorbent assay. Samples from 76 children with PARDS (11 deaths, 14%) were collected early [median 15 (IQR 7, 21) h] after PARDS onset. Nucleosome levels were higher in nonsurvivors [0.59 AU (IQR 0.46, 0.84)] relative to survivors [0.21 AU (IQR 0.08, 0.33), rank sum P < 0.001]. Nucleosome levels were not associated with either Berlin (P = 0.845) or PALICC (P = 0.886) oxygenation categories, nor with etiology of PARDS (P = 0.527). Nucleosomes were correlated with increasing numbers of nonpulmonary organ failures (P = 0.009 for trend), and were higher in patients whose PaO2 /FiO2 worsened (P = 0.012) over the first 72 h of PARDS. In regression analysis, nucleosome levels were independently associated with mortality after adjusting for either age, severity of illness score, number of nonpulmonary organ failures, vasopressor score, or PaO2 /FiO2 (all P < 0.05). In conclusion, plasma nucleosome levels in early PARDS were associated with increased mortality, correlated with number of nonpulmonary organ failures, and preceded worsening oxygenation. The potential utility of this biomarker for prognostication, risk stratification, and mechanistic insight should be investigated further.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  ARDS; PARDS; acute respiratory distress syndrome; nucleosomes; pediatric acute respiratory distress syndrome

Mesh:

Substances:

Year:  2016        PMID: 27130528      PMCID: PMC4935473          DOI: 10.1152/ajplung.00067.2016

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  42 in total

1.  Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference.

Authors: 
Journal:  Pediatr Crit Care Med       Date:  2015-06       Impact factor: 3.624

2.  Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure.

Authors:  Daniel Trachsel; Brian W McCrindle; Satoshi Nakagawa; Desmond Bohn
Journal:  Am J Respir Crit Care Med       Date:  2005-04-07       Impact factor: 21.405

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

4.  Extracellular histones play an inflammatory role in acid aspiration-induced acute respiratory distress syndrome.

Authors:  Yanlin Zhang; Zongmei Wen; Li Guan; Ping Jiang; Tao Gu; Jinyuan Zhao; Xin Lv; Tao Wen
Journal:  Anesthesiology       Date:  2015-01       Impact factor: 7.892

5.  Pediatric Acute Lung Injury Epidemiology and Natural History study: Incidence and outcome of the acute respiratory distress syndrome in children.

Authors:  Yolanda López-Fernández; Amelia Martínez-de Azagra; Pedro de la Oliva; Vicent Modesto; Juan I Sánchez; Julio Parrilla; María José Arroyo; Susana Beatriz Reyes; Martí Pons-Ódena; Jesús López-Herce; Rosa Lidia Fernández; Robert M Kacmarek; Jesús Villar
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

6.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

Review 7.  Clinical use of circulating nucleosomes.

Authors:  Stefan Holdenrieder; Petra Stieber
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

8.  An early PEEP/FIO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome.

Authors:  Jesús Villar; Lina Pérez-Méndez; José López; Javier Belda; Jesús Blanco; Iñaki Saralegui; Fernando Suárez-Sipmann; Julia López; Santiago Lubillo; Robert M Kacmarek
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

9.  Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.

Authors:  Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

10.  Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study).

Authors:  Fabián Jaimes; Gisela De La Rosa; Carlos Morales; Fernando Fortich; Clara Arango; Daniel Aguirre; Alvaro Muñoz
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

View more
  9 in total

1.  Differentiating children with sepsis with and without acute respiratory distress syndrome using proteomics.

Authors:  Nadir Yehya; Hossein Fazelinia; Deanne M Taylor; Gladys G Lawrence; Lynn A Spruce; Jill M Thompson; Susan S Margulies; Steven H Seeholzer; G Scott Worthen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-01-05       Impact factor: 5.464

2.  Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome.

Authors:  Jane E Whitney; Rui Feng; Natalka Koterba; Fang Chen; Jenny Bush; Kathryn Graham; Simon F Lacey; Jan Joseph Melenhorst; Samir M Parikh; Scott L Weiss; Nadir Yehya
Journal:  Crit Care Explor       Date:  2020-12-04

3.  Biomarkers associated with mortality in pediatric patients with cardiac arrest and acute respiratory distress syndrome.

Authors:  Monique M Gardner; Matthew P Kirschen; Hector R Wong; Daniel J McKeone; E Scott Halstead; Jill M Thompson; Adam S Himebauch; Alexis A Topjian; Nadir Yehya
Journal:  Resuscitation       Date:  2021-12-03       Impact factor: 5.262

Review 4.  The Organ Trail: A Review of Biomarkers of Organ Failure.

Authors:  Long Dao; Dristhi Ragoonanan; Sofia Yi; Rita Swinford; Demetrios Petropoulos; Kris M Mahadeo; Shulin Li
Journal:  Front Oncol       Date:  2020-11-11       Impact factor: 6.244

5.  Peripheral blood transcriptomic sub-phenotypes of pediatric acute respiratory distress syndrome.

Authors:  Nadir Yehya; Brian M Varisco; Neal J Thomas; Hector R Wong; Jason D Christie; Rui Feng
Journal:  Crit Care       Date:  2020-12-07       Impact factor: 9.097

Review 6.  Potential therapeutics in pediatric acute respiratory distress syndrome: what does the immune system have to offer? A narrative review.

Authors:  Nadir Yehya
Journal:  Transl Pediatr       Date:  2021-10

7.  Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis.

Authors:  Jane E Whitney; Binqing Zhang; Natalka Koterba; Fang Chen; Jenny Bush; Kathryn Graham; Simon F Lacey; Jan Joseph Melenhorst; David T Teachey; Janell L Mensinger; Nadir Yehya; Scott L Weiss
Journal:  Crit Care Med       Date:  2020-03       Impact factor: 7.598

8.  Plasma Nucleosomes Are Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Nadir Yehya; Hossein Fazelinia; Gladys G Lawrence; Lynn A Spruce; Mark V Mai; G Scott Worthen; Jason D Christie
Journal:  Crit Care Med       Date:  2021-07-01       Impact factor: 9.296

9.  Circulating Neurofilament Light Chain Is Associated With Survival After Pediatric Cardiac Arrest.

Authors:  Matthew P Kirschen; Nadir Yehya; Kathryn Graham; Todd Kilbaugh; Robert A Berg; Alexis Topjian; Ramon Diaz-Arrastia
Journal:  Pediatr Crit Care Med       Date:  2020-07       Impact factor: 3.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.